IPAD-DB ID | D00059 |
Name | Todralazine |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 1 H 1 2 N 4 O 2 |
Molecular Weight | 232.24 g/mol |
IUPAC Name | ethyl N-(phthalazin-1-ylamino)carbamate |
InChI | InChI=1S/C11H12N4O2/c1-2-17-11(16)15-14-10-9-6-4-3-5-8(9)7-12-13-10/h3-7H,2H2,1H3,(H,13,14)(H,15,16) |
InChIKey | WGZDBVOTUVNQFP-UHFFFAOYSA-N |
Canonical SMILES | CCOC(=O)NNC1=NN=CC2=CC=CC=C21 |
PubChem CID | 5501 |
DrugBank Accession Number | - |
CAS Registry Number | 14679-73-3 |
Molecular Weight(Computed by SwissADME) | 232.24 |
Hac(Computed by SwissADME) | 17 |
Volume(Computed by ADMETlab 2.0) | 227.448 |
Density(Computed by ADMETlab 2.0) | 1.02 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 10 |
nHet(Computed by ADMETlab 2.0) | 6 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 13 |
Flexibility(Computed by ADMETlab 2.0) | 0.308 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.587 |
LogD(Computed by ADMETlab 2.0) | 2.783 |
logP(Computed by ADMETlab 2.0) | 2.833 |
TPSA(Computed by SwissADME) | 76.14 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 5 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.28 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |